Pharmacovigilance study and genetic target prediction analysis of FDA adverse event reporting system for anticancer drug-associated interstitial lung disease

Naunyn-Schmiedeberg s Archives of Pharmacology 2026

View at publisher

Authors: Shun Li, Weijian Miao, Qimeng Tao, Jingjing Sun, Zhifei Huang, Yan Zhou, Hao Jiang

DOI: 10.1007/s00210-026-05016-2

Cited by: 2

References: 44

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pharmacovigilance and Adverse Drug Reactions Lung Cancer Treatments and Mutations

References 44